NovoCure NVCR Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $93.55M-42.9% | $163.77M-32.0% | $240.82M+109% | $115.33M-44.8% | ||
| $354.13M-55.5% | $796.11M+18.9% | $669.8M-21.6% | $854.1M+17.2% | ||
| $9.84M+323% | $2.33M+33.5% | $1.74M+243% | $508K-37.1% | ||
| $41.11M+17.2% | $35.09M-8.0% | $38.15M+29.9% | $29.38M+20.3% | ||
| $646.73M-41.6% | $1.11B+7.0% | $1.03B-6.9% | $1.11B+3.5% | ||
| $77.61M-0.1% | $77.66M+50.9% | $51.48M+57.5% | $32.68M+44.0% | ||
| $47.33M+74.5% | $27.12M-22.1% | $34.84M+47.6% | $23.6M+29.2% | ||
| $10.6M-27.5% | $14.62M+4.3% | $14.02M+25.6% | $11.16M-7.7% | ||
| $157.6M+17.4% | $134.21M+20.1% | $111.72M+39.4% | $80.12M+21.4% | ||
| $804.33M-35.2% | $1.24B+8.3% | $1.15B-3.8% | $1.19B+4.6% | ||
| $122.23M+16.3% | $105.09M+11.3% | $94.39M+10.8% | $85.2M+17.4% | ||
| $223.23M-70.5% | $756.39M+322% | $179.12M+12.8% | $158.78M+11.3% | ||
| $41.65M+109% | $19.97M-27.2% | $27.42M+46.1% | $18.76M+44.4% | ||
| $240.63M+93.7% | $124.21M-79.5% | $604.52M+2.2% | $591.7M+0.9% | ||
| $463.86M-47.3% | $880.61M+12.4% | $783.63M+4.4% | $750.48M+2.9% | ||
| $0— | $0— | $0— | $0— | ||
| $1.63B+7.5% | $1.52B+12.3% | $1.35B+10.8% | $1.22B+11.1% | ||
| -$1.29B-11.8% | -$1.15B-17.1% | -$985.5M-26.6% | -$778.46M-13.5% | ||
| -$3.44M+37.4% | -$5.5M-0.6% | -$5.47M-125% | -$2.43M+23.2% | ||
| $340.47M-5.5% | $360.18M-0.6% | $362.5M-17.8% | $441.17M+7.5% | ||
| $804.33M-35.2% | $1.24B+8.3% | $1.15B-3.8% | $1.19B+4.6% | ||
| —— | —— | —— | —— | ||
| $58.67M+67.3% | $35.06M+54.6% | $22.68M-12.6% | $25.96M+52.5% | ||
| $10.6M-27.5% | $14.62M+4.3% | $14.02M+25.6% | $11.16M-7.7% | ||
| $47.33M+74.5% | $27.12M-22.1% | $34.84M+47.6% | $23.6M+29.2% | ||
| $22.07M+49.0% | $14.81M+30.1% | $11.38M-10.2% | $12.68M-1.8% | ||
| $47.33M+74.5% | $27.12M-22.1% | $34.84M+47.6% | $23.6M+29.2% | ||
| $10.6M-27.5% | $14.62M+4.3% | $14.02M+25.6% | $11.16M-7.7% | ||
| $47.33M+74.5% | $27.12M-22.1% | $34.84M+47.6% | $23.6M+29.2% | ||
| $10.6M-27.5% | $14.62M+4.3% | $14.02M+25.6% | $11.16M-7.7% | ||
| $101M+8.4% | $93.15M+9.9% | $84.72M+15.1% | $73.58M+5.1% | ||
| $195.05M+100% | $97.3M— | $0— | —— | ||
| $53.31M+91.2% | $27.88M-95.4% | $604.47M+2.4% | $590.08M+1.4% | ||
| $0— | $0— | $0— | $0— | ||
| $3.94M-43.3% | $6.94M-16.0% | $8.26M+87.5% | $4.4M-3.1% | ||
| $195.05M+100% | $97.3M— | $0— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are NovoCure's total assets?
- NovoCure (NVCR) holds $787.9M in total assets, down 36.9% year over year.
- How much debt does NovoCure have?
- NovoCure carries $39.5M in total debt against $330.7M of shareholders' equity, a debt-to-equity ratio of 0.12.
- How much cash does NovoCure have?
- NovoCure holds $87.5M in cash and equivalents.
- Can NovoCure cover its short-term obligations?
- Its current ratio is 2.90 — current assets exceed current liabilities.
- Where does NovoCure's balance sheet data come from?
- Every line is extracted from NovoCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
